We use cookies to improve the function of this site and enhance the user experience.
Learn more about our cookie policy and how to modify your cookie settings.
UK/CORP/15-0012l. Date of preparation: July 2015
United Kingdom
Include All CSL Behring Country Sites

Patient Information

CSL Behring UK Ltd is committed to improving the quality of life for patients with rare diseases, including:

Congenital fibrinogen deficiency

Where an essential protein required for a blood clot to form is either missing, significantly reduced or dysfunctional.

Haemolytic disease of the newborn

A severe form of anaemia caused when the blood group of the mother and baby are not compatible.


A problem with the blood where there is not enough of one of the clotting factors needed for clots to form.

Hereditary angiodema

A rare genetic condition that can cause considerable swelling in various body tissues.

Immune deficiency disorders

Where one or more components of the immune system are either missing or not working properly.

Neurological disorders

Diseases of the central and peripheral nervous system. e.g. the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, automatic nervous system, neuromuscular junction and muscles.

Rapid warfarin reversal

Warfarin is a medicine which thins the blood and is used to reduce the risk of blood clots. When a person on warfarin experiences a bleeding episode, it may be necessary to reverse the effects of warfarin to stop the bleeding.

Von Willebrand disease.

A problem with one of the clotting factors in the blood; this particular clotting factor is known as von Willebrand factor.

UK/CORP/15-0012e Date of preparation: July 2015